mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.07 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.07 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.07 |